Cagrilintide

Clinical research demonstrates that this long-acting amylin analogue delays gastric emptying and enhances central satiety signaling, showing powerful weight management and appetite-reducing effects, particularly when paired synergistically with GLP-1 agonists.

The products available on this website are intended solely for laboratory research and in vitro or animal development studies, and are not to be used for human consumption, veterinary administration to companion animals or livestock, diagnostic procedures, or therapeutic applications. These statements and products have not been evaluated or approved by Health Canada. They are not intended to diagnose, treat, cure, or prevent any medical condition or disease in humans or animals. By purchasing from this site, the buyer acknowledges and agrees that the materials are classified strictly as research chemicals and that any personal administration, clinical use, or misuse is entirely at their own risk.